(Q40914926)

24 September 2017

0 references

Dapagliflozin-induced weight loss affects 24-week glycated haemoglobin and blood pressure levels (English)

1 reference

24 September 2017

C D Sjöström

1

1 reference

24 September 2017

M Hashemi

2

1 reference

24 September 2017

J Sugg

3

1 reference

24 September 2017

A Ptaszynska

4

1 reference

24 September 2017

E Johnsson

5

1 reference

24 September 2017

publication date

21 May 2015

1 reference

Diabetes, Obesity and Metabolism

24 September 2017

published in

1 reference

24 September 2017

volume

17

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

809-812

1 reference

24 September 2017

1 reference

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

21 January 2018

1 reference

Inhibition of the sodium glucose co-transporter-2: its beneficial action and potential combination therapy for type 2 diabetes mellitus

21 January 2018

1 reference

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

21 January 2018

1 reference

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin

21 January 2018

1 reference

The importance of weight management in type 2 diabetes mellitus.

21 January 2018

1 reference

Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study

21 January 2018

1 reference

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.

21 January 2018

1 reference

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus

21 January 2018

1 reference

Effect of an 18-month physical activity and weight loss intervention on body composition in overweight and obese older adults

21 January 2018

1 reference

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12500

1 reference

24 September 2017

1 reference